In 2004, Song et al firstly found that carriers of the APOE-ε4 allele had a 42% increased risk for CAD (OR = 1.42, 95% CI = 1.26–1.61) compared with the ε3/ε3 genotypes (Song et al., 2004). The gene discussed is APOE; the disease is coronary artery disorder.